Investor Information

 

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the 

  • TSX Venture Exchange (TLT-TSVX) and the
  • OTCQB (TLTFF)

Data last updated on March 14, 2019


 

Number of common shares outstanding

Basic: 204,275,375

Warrants: 91,814,705

Options: 16,920,000 

Fully Diluted: 313,010,080

Insider Ownership: 7% (9.3% fully diluted)

[stockdio-historical-chart]

Financial Filings

 
Downloaded 405 times.
Downloaded 326 times.
Downloaded 259 times.
Downloaded 172 times.
Downloaded 98 times.
Downloaded 55 times.
Downloaded 9 times.
Downloaded 9 times.
Downloaded 11 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 3 times.
Downloaded 2 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 2 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 5 times.
 
Downloaded 222 times.
Downloaded 172 times.
Downloaded 116 times.
Downloaded 78 times.
Downloaded 44 times.
Downloaded 38 times.
Downloaded 4 times.
Downloaded 6 times.
Downloaded 7 times.
Downloaded 0 times.
Downloaded 4 times.
Downloaded 0 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 3 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 6 times.
SEDAR Filings (System for Electronic Document Analysis and Retrieval)

Theralase's complete public securities documents are available in English and French on SEDAR.